Skip to main content
. 2021 Sep 10;8:746113. doi: 10.3389/fnut.2021.746113

Figure 3.

Figure 3

(A) Reverse-phase HPLC chromatogram of second-step purification of the G3 fraction; (B) inhibitory activity of six pooled fractions (S1–S6).